In February 2010, aztreonam for inhalation solution (Cayston; Gilead) — an inhalable formulation of the monobactam antibiotic aztreonam and lysine — was approved by the US FDA to improve ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback